Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1303974-96-0

Post Buying Request

1303974-96-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1303974-96-0 Usage

Description

Methyl 1-Boc-5-oxo-piperidine-3-carboxylate is a chemical compound with the molecular formula C12H19NO5, derived from piperidine, a cyclic amine. It features a tert-butyloxycarbonyl (1-Boc) protecting group and an oxo group, indicating the presence of a carbonyl group. Methyl 1-Boc-5-oxo-piperidine-3-carboxylate is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals, and is typically handled under strict laboratory conditions due to its potential reactivity and toxicity.

Uses

Used in Pharmaceutical Industry:
Methyl 1-Boc-5-oxo-piperidine-3-carboxylate is used as a key intermediate in the synthesis of various pharmaceuticals. Its 1-Boc protecting group allows for selective reactions to occur at other sites on the molecule, facilitating the production of complex drug molecules.
Used in Agrochemical Industry:
In the agrochemical industry, Methyl 1-Boc-5-oxo-piperidine-3-carboxylate serves as an intermediate in the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural products.
Used in Organic Synthesis:
Methyl 1-Boc-5-oxo-piperidine-3-carboxylate is utilized in organic synthesis for the preparation of various organic compounds. Its functional groups, including the carbonyl and the Boc protecting group, enable a range of reactions that can be employed to construct diverse organic molecules.

Check Digit Verification of cas no

The CAS Registry Mumber 1303974-96-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,3,9,7 and 4 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1303974-96:
(9*1)+(8*3)+(7*0)+(6*3)+(5*9)+(4*7)+(3*4)+(2*9)+(1*6)=160
160 % 10 = 0
So 1303974-96-0 is a valid CAS Registry Number.

1303974-96-0Relevant articles and documents

PHENOXY-PYRIDYL-PYRIMIDINE COMPOUNDS AND METHODS OF USE

-

Paragraph 0588, (2020/05/06)

Described herein are phenoxy-pyridyl -pyrimidine compounds with inositol requiring enzyme 1 (IRE1) modulation activity or function having the Formula I structure or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula I compounds, as well as methods of using such IRE1 modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.

Novel Allosteric Ligands of γ-Aminobutyric Acid Transporter 1 (GAT1) by MS Based Screening of Pseudostatic Hydrazone Libraries

Hauke, Tobias J.,Wein, Thomas,H?fner, Georg,Wanner, Klaus T.

, p. 10310 - 10332 (2018/11/23)

This study describes the screening of dynamic combinatorial libraries based on nipecotic acid as core structure with substituents attached to the 5- instead of the common 1-position for the search of novel inhibitors of the GABA transporter GAT1. The generated pseudostatic hydrazone libraries included a total of nearly 900 compounds and were screened for their binding affinities toward GAT1 in competitive mass spectrometry (MS) based Binding Assays. Characterization of the hydrazones with the highest affinities (with cis-configured rac-16gf bearing a 5-(1-naphthyl)furan-2-yl residue and a four atom spacer being the most potent) in binding and uptake experiments revealed an allosteric interaction at GAT1, which was not reported for any other nipecotic acid derivative up to now. Therefore, the herein introduced 5-substituted nipecotic acid derivatives could serve as valuable tools for investigations of allosterically modulated GABA transport mediated by GAT1 and furthermore as starting point for a new class of GAT1 inhibitors.

NITROGEN-CONTAINING SATURATED HETEROCYCLIC COMPOUND

-

Paragraph 0405-0407, (2016/08/29)

The present invention provides a compound represented by the following formula (I) or its pharmaceutically acceptable salt: [wherein, R1 represents optionally substituted C1-4 alkyl, n shows integer of 1 to 4, R2 represents optionally substituted C1-4 alkyl or hydrogen atom, R3 represents optionally substituted C1-4 alkyl, R4a, R4b, R4c, and R4d, similarly or differently, represent optionally substituted C6-14 aryl, optionally substituted C1-4 alkyl, or hydrogen atom and the like, A represents optionally substituted C6-14 aryl or optionally substituted 5 to 11 membered heteroaryl].

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1303974-96-0